Camson Bio Technologies has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, Meeting of Board of Directors of the Company will be held on Saturday, 10th February, 2018, to consider and approve the Un-audited Financial Results of the Company along with Limited Review Report for the quarter ended 31st December, 2017. For the purpose of the above and as per the Company’s Code of Conduct for Prevention of Insider Trading as framed under the SEBI (Prevention of Insider Trading) Regulations, 2015, the trading window for dealing in the Securities of the Company will be closed from Saturday, 3rd February, 2018 to Monday, 12th February, 2018 for the specified persons as per the said Code of Conduct.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Venkys India | 1578.60 |
| Mangalam Global Ent | 14.07 |
| Kaveri Seed | 974.15 |
| Regaal Resources | 83.50 |
| Simran Farms | 159.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: